About RevolKa
RevolKa is a company based in Chuo (Japan) founded in 2021. RevolKa has raised $3.1 million across 2 funding rounds from investors including D3, DEEPCORE and Tohoku University Venture Partners. RevolKa operates in a competitive market with competitors including Zephyr AI, Precisionlife, Chemify, Transaction Data Systems and OpenEye Scientific, among others.
- Headquarter Chuo, Japan
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.1 M (USD)
in 2 rounds
-
Latest Funding Round
$1.4 M (USD), Series A
May 20, 2025
-
Investors
D3
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of RevolKa
RevolKa has successfully raised a total of $3.1M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $1.4 million completed in May 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in RevolKa
RevolKa has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include D3, DEEPCORE and Tohoku University Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
DEEPCORE is engaged in developing AI-driven technology solutions.
|
Locked | Locked | Locked | |
|
Venture investment support for Tohoku University's research outcomes is provided.
|
Locked | Locked | Locked |
Investor details for RevolKa
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by RevolKa
Investment portfolio details for RevolKa
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - RevolKa
Detailed financials for RevolKa
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Revolka Comparisons
Peer comparison for RevolKa
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of RevolKa
RevolKa operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zephyr AI, Precisionlife, Chemify, Transaction Data Systems and OpenEye Scientific, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of AI development services for biopharma sector
|
|
| Locked | Locked | Locked |
AI-enabled platforms for drug discovery and precision medicine are developed.
|
|
| Locked | Locked | Locked |
Software development services are provided for pharmaceutical and materials research.
|
|
| Locked | Locked | Locked |
Software development services are provided to the biopharma sector.
|
|
| Locked | Locked | Locked |
Drug discovery and design are enabled by a cloud-based platform.
|
Detailed competitors of RevolKa
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Revolka
Complete news archive for RevolKa
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RevolKa
RevolKa was founded in 2021 and raised its 1st funding round 3 years after it was founded.
RevolKa is headquartered in Chuo, Japan. It is registered at Chuo, Yamanashi Prefecture, Japan.
Shiro Kataoka is the current CEO of RevolKa.
RevolKa is a funded company, having raised a total of $3.1M across 2 funding rounds to date.
RevolKa was established in 2021 and is based in Chuo City, Japan. AI development services are delivered specifically to the biopharma industry. Operations focus on supporting pharmaceutical and biotechnology firms through customized AI solutions. The company is led by CEO Shiro Kataoka, with activities centered on technological innovation for sector-specific needs. Geographic emphasis remains on Japanese operations, extending services to international biopharma clients as required.
RevolKa's top competitors include Chemify, Zephyr AI and Precisionlife.
RevolKa has 4 investors. Key investors include D3, DEEPCORE, Tohoku University Venture Partners, and SBI Investment.